Posted by: drugsinus on: December 2, 2009
Sanofi-Aventis continued the winnowing of its U.S. sales force by telling employees today that another 750 sales jobs are being cut. Like most of big pharma, Sanofi is facing stiff generic competition in the U.S. Some of its biggest sellers, from sleeping pill Ambien to the cancer drug Eloxatin, have gone generic, and one of [...]
Posted by: drugsinus on: November 16, 2009
ORLANDO — The results of a much-awaited study could hardly be worse for Merck‘s big-selling cholesterol drugs Zetia and Vytorin. A small 208-person trial that used ultrasound to examine arteries found that Zetia was clearly inferior to a version of the old drug niacin in preventing clogged arteries. Moreover, in a surprise finding, patients on [...]
